SCHEMBL7987930

SCHEMBL7987930

CCC(=O)Nc1ncn(CCc2ccccc2)c1C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
CNOT7 Q9UIV1 5/20 0.43
ALDH1A1 P00352 6/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HTT P42858 2/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.41
HSD17B10 Q99714 2/20 0.41
LMNA P02545 3/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 2/20 0.39
ADORA2A P29274 1/20 0.39
MAPT P10636 1/20 0.39
ADRA1D P25100 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974138 0.94 KMT2A (0.52) KMT2ACNOT7ALDH1A1SMN1; SMN2HTT
SCHEMBL7991565 0.89 TSHR (0.49) KMT2AALDH1A1SMN1; SMN2HTTHSD17B10
SCHEMBL7984368 0.85 GSK3B (0.44) KMT2ACNOT7ALDH1A1SMN1; SMN2RAB9A
SCHEMBL7987988 0.85 GAA (0.47) KMT2ACNOT7ALDH1A1SMN1; SMN2HTT
SCHEMBL7991860 0.84 ADORA2A (0.46) KMT2ACNOT7SMN1; SMN2HTTRAB9A
SCHEMBL7987837 0.84 RECQL (0.47) KMT2AALDH1A1SMN1; SMN2HTTMEN1
SCHEMBL7974223 0.82 RAB9A (0.46) ALDH1A1SMN1; SMN2HTTRAB9ANPC1
SCHEMBL7988641 0.82 KMT2A (0.44) KMT2AALDH1A1SMN1; SMN2RAB9AMEN1
SCHEMBL7988382 0.80 KMT2A (0.41) KMT2AALDH1A1SMN1; SMN2HTTRAB9A
SCHEMBL7987555 0.80 GAA (0.47) KMT2AALDH1A1MEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed